Evidence map›Paper›PMID 27867497›Full record

ArticleBoneKEy reports2016

Murine models of breast cancer bone metastasis.

Laura E Wright, Penelope D Ottewell, Nadia Rucci, Olivier Peyruchaud, Gabriel M Pagnotti, Antonella Chiechi, Jeroen T Buijs, Julie A Sterling

Abstract read
In one paragraph

Article in BoneKEy reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Between Prometheus and Thanatos: Reflections on Intracardiac Injection Models for Metastasis in Mice.Journal of the American Association for Laboratory Animal Science : JAALAS · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Mouse Models of Breast Cancer Bone Metastasis.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Laura E WrightDivision of Endocrinology, Department of Medicine, Indiana University , Indianapolis, IN, USA.
Penelope D OttewellDepartment of Oncology, Mellanby Center for Bone Research, University of Sheffield , Sheffield, UK.
Nadia RucciDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila , L'Aquila, Italy.
Olivier PeyruchaudPhysiopathologie, Diagnostic et Traitements des Maladies Osseuses, INSERM, UMR_S1033 , Lyon, France.
Gabriel M PagnottiDepartment of Biomedical Engineering, Stony Brook University , Stony Brook, NY, USA.
Antonella ChiechiDivision of Endocrinology, Department of Medicine, Indiana University , Indianapolis, IN, USA.
Jeroen T BuijsDepartment of Thrombosis & Hemostasis, Leiden University Medical Center , Leiden, The Netherlands.
Julie A SterlingDepartment of Medicine, Division of Clinical Pharmacology, Vanderbilt University, Nashville, TN, USA; Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN, USA.
Leiden University Medical Center · NLStony Brook University · USUniversity of L'Aquila · IT

Funding

AUGMENTATION OF TRABECULAR BONE BY LOW MAGNITUDE STRAINR01AR043498 · NIAMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI RUBIN, CLINTON T · 1997 to 2012
$2.8M
The Role of Mechanotransduction in Progression of Tumor-induced Bone DiseaseR01CA163499 · NCI · VANDERBILT UNIVERSITY · PI GUELCHER, SCOTT A, RHOADES (STERLING), JULIE A · 2012 to 2016
$1.5M
Targeting the Bone Microenvironment to Reduce Tumor-induced Bone DiseaseI01BX001957 · VA · VETERANS HEALTH ADMINISTRATION · PI RHOADES (STERLING), JULIE A · 2013 to 2025
–
BLRD VA I01 BX001957NCI NIH HHS R01 CA163499NIAMS NIH HHS R01 AR043498
6 · The paper itself

Abstract

Bone metastases cause significant morbidity and mortality in late-stage breast cancer patients and are currently considered incurable. Investigators rely on translational models to better understand the pathogenesis of skeletal complications of malignancy in order to identify therapeutic targets that may ultimately prevent and treat solid tumor metastasis to bone. Many experimental models of breast cancer bone metastases are in use today, each with its own caveats. In this methods review, we characterize the bone phenotype of commonly utilized human- and murine-derived breast cell lines that elicit osteoblastic and/or osteolytic destruction of bone in mice and report methods for optimizing tumor-take in murine models of bone metastasis. We then provide protocols for four of the most common xenograft and syngeneic inoculation routes for modeling breast cancer metastasis to the skeleton in mice, including the intra-cardiac, intra-arterial, orthotopic and intra-tibial methods of tumor cell injection. Recommendations for

Identifiers

PMID27867497
PMCPMC5108088
OpenAlexW2381577556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.